ReviewDrug discovery today2021

A paradigm shift in cancer nanomedicine: from traditional tumor targeting to leveraging the immune system.

Alexandros Marios Sofias et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.